Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons.

Akiyama T, Suzuki N, Ishikawa M, Fujimori K, Sone T, Kawada J, Funayama R, Fujishima F, Mitsuzawa S, Ikeda K, Ono H, Shijo T, Osana S, Shirota M, Nakagawa T, Kitajima Y, Nishiyama A, Izumi R, Morimoto S, Okada Y, Kamei T, Nishida M, Nogami M, Kaneda S, Ikeuchi Y, Mitsuhashi H, Nakayama K, Fujii T, Warita H, Okano H, Aoki M.

EBioMedicine. 2019 Jul;45:362-378. doi: 10.1016/j.ebiom.2019.06.013. Epub 2019 Jun 29.

2.

The updated retrospective questionnaire study of sporadic inclusion body myositis in Japan.

Suzuki N, Mori-Yoshimura M, Yamashita S, Nakano S, Murata KY, Mori M, Inamori Y, Matsui N, Kimura E, Kusaka H, Kondo T, Ito H, Higuchi I, Hashiguchi A, Nodera H, Kaji R, Tateyama M, Izumi R, Ono H, Kato M, Warita H, Takahashi T, Nishino I, Aoki M.

Orphanet J Rare Dis. 2019 Jun 26;14(1):155. doi: 10.1186/s13023-019-1122-5.

3.

Interstitial pneumonia and other adverse events in riluzole-administered amyotrophic lateral sclerosis patients: a retrospective observational study.

Inoue-Shibui A, Kato M, Suzuki N, Kobayashi J, Takai Y, Izumi R, Kawauchi Y, Kuroda H, Warita H, Aoki M.

BMC Neurol. 2019 Apr 27;19(1):72. doi: 10.1186/s12883-019-1299-1.

4.

Safety, Tolerability, and Pharmacodynamics of Intrathecal Injection of Recombinant Human HGF (KP-100) in Subjects With Amyotrophic Lateral Sclerosis: A Phase I Trial.

Warita H, Kato M, Asada R, Yamashita A, Hayata D, Adachi K, Aoki M.

J Clin Pharmacol. 2019 May;59(5):677-687. doi: 10.1002/jcph.1355. Epub 2018 Dec 11.

PMID:
30536581
5.

Antagonizing bone morphogenetic protein 4 attenuates disease progression in a rat model of amyotrophic lateral sclerosis.

Shijo T, Warita H, Suzuki N, Ikeda K, Mitsuzawa S, Akiyama T, Ono H, Nishiyama A, Izumi R, Kitajima Y, Aoki M.

Exp Neurol. 2018 Sep;307:164-179. doi: 10.1016/j.expneurol.2018.06.009. Epub 2018 Jun 20.

PMID:
29932880
6.

TARDBP p.G376D mutation, found in rapid progressive familial ALS, induces mislocalization of TDP-43.

Mitsuzawa S, Akiyama T, Nishiyama A, Suzuki N, Kato M, Warita H, Izumi R, Osana S, Koyama S, Kato T, Suzuki Y, Aoki M.

eNeurologicalSci. 2018 Apr 12;11:20-22. doi: 10.1016/j.ensci.2018.04.001. eCollection 2018 Jun. No abstract available.

7.

Rostrocaudal Areal Patterning of Human PSC-Derived Cortical Neurons by FGF8 Signaling.

Imaizumi K, Fujimori K, Ishii S, Otomo A, Hosoi Y, Miyajima H, Warita H, Aoki M, Hadano S, Akamatsu W, Okano H.

eNeuro. 2018 Apr 26;5(2). pii: ENEURO.0368-17.2018. doi: 10.1523/ENEURO.0368-17.2018. eCollection 2018 Mar-Apr.

8.

Aberrant astrocytic expression of chondroitin sulfate proteoglycan receptors in a rat model of amyotrophic lateral sclerosis.

Shijo T, Warita H, Suzuki N, Kitajima Y, Ikeda K, Akiyama T, Ono H, Mitsuzawa S, Nishiyama A, Izumi R, Aoki M.

J Neurosci Res. 2018 Feb;96(2):222-233. doi: 10.1002/jnr.24127. Epub 2017 Jul 28.

PMID:
28752900
9.

[Therapeutic development for GNE myopathy.]

Suzuki N, Izumi R, Kato M, Warita H, Aoki M.

Clin Calcium. 2017;27(3):429-434. doi: CliCa1703429434. Japanese.

PMID:
28232658
10.

Comprehensive targeted next-generation sequencing in Japanese familial amyotrophic lateral sclerosis.

Nishiyama A, Niihori T, Warita H, Izumi R, Akiyama T, Kato M, Suzuki N, Aoki Y, Aoki M.

Neurobiol Aging. 2017 May;53:194.e1-194.e8. doi: 10.1016/j.neurobiolaging.2017.01.004. Epub 2017 Jan 10.

PMID:
28160950
11.

Altered Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes.

Ishigaki S, Fujioka Y, Okada Y, Riku Y, Udagawa T, Honda D, Yokoi S, Endo K, Ikenaka K, Takagi S, Iguchi Y, Sahara N, Takashima A, Okano H, Yoshida M, Warita H, Aoki M, Watanabe H, Okado H, Katsuno M, Sobue G.

Cell Rep. 2017 Jan 31;18(5):1118-1131. doi: 10.1016/j.celrep.2017.01.013.

12.

Multicenter questionnaire survey for sporadic inclusion body myositis in Japan.

Suzuki N, Mori-Yoshimura M, Yamashita S, Nakano S, Murata KY, Inamori Y, Matsui N, Kimura E, Kusaka H, Kondo T, Higuchi I, Kaji R, Tateyama M, Izumi R, Ono H, Kato M, Warita H, Takahashi T, Nishino I, Aoki M.

Orphanet J Rare Dis. 2016 Nov 8;11(1):146.

13.

Maintenance of Bone Homeostasis by DLL1-Mediated Notch Signaling.

Muguruma Y, Hozumi K, Warita H, Yahata T, Uno T, Ito M, Ando K.

J Cell Physiol. 2017 Sep;232(9):2569-2580. doi: 10.1002/jcp.25647. Epub 2017 Mar 31.

14.

Prominent sensory involvement in a case of familial amyotrophic lateral sclerosis carrying the L8V SOD1 mutation.

Nishiyama A, Warita H, Takahashi T, Suzuki N, Nishiyama S, Tano O, Akiyama T, Watanabe Y, Takahashi K, Kuroda H, Kato M, Tateyama M, Niihori T, Aoki Y, Aoki M.

Clin Neurol Neurosurg. 2016 Nov;150:194-196. doi: 10.1016/j.clineuro.2016.08.008. Epub 2016 Aug 6. No abstract available.

PMID:
27543311
15.

Genetic profile for suspected dysferlinopathy identified by targeted next-generation sequencing.

Izumi R, Niihori T, Takahashi T, Suzuki N, Tateyama M, Watanabe C, Sugie K, Nakanishi H, Sobue G, Kato M, Warita H, Aoki Y, Aoki M.

Neurol Genet. 2015 Dec 10;1(4):e36. doi: 10.1212/NXG.0000000000000036. eCollection 2015 Dec.

16.

Isolated inclusion body myopathy caused by a multisystem proteinopathy-linked hnRNPA1 mutation.

Izumi R, Warita H, Niihori T, Takahashi T, Tateyama M, Suzuki N, Nishiyama A, Shirota M, Funayama R, Nakayama K, Mitsuhashi S, Nishino I, Aoki Y, Aoki M.

Neurol Genet. 2015 Sep 24;1(3):e23. doi: 10.1212/NXG.0000000000000023. eCollection 2015 Oct.

17.

Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells.

Ichiyanagi N, Fujimori K, Yano M, Ishihara-Fujisaki C, Sone T, Akiyama T, Okada Y, Akamatsu W, Matsumoto T, Ishikawa M, Nishimoto Y, Ishihara Y, Sakuma T, Yamamoto T, Tsuiji H, Suzuki N, Warita H, Aoki M, Okano H.

Stem Cell Reports. 2016 Apr 12;6(4):496-510. doi: 10.1016/j.stemcr.2016.02.011. Epub 2016 Mar 17.

18.

Genotype-phenotype relationships in familial amyotrophic lateral sclerosis with FUS/TLS mutations in Japan.

Akiyama T, Warita H, Kato M, Nishiyama A, Izumi R, Ikeda C, Kamada M, Suzuki N, Aoki M.

Muscle Nerve. 2016 Sep;54(3):398-404. doi: 10.1002/mus.25061. Epub 2016 Feb 23.

PMID:
26823199
19.

Corticotropin-Releasing Hormone Receptor 2 Gene Variants in Irritable Bowel Syndrome.

Komuro H, Sato N, Sasaki A, Suzuki N, Kano M, Tanaka Y, Yamaguchi-Kabata Y, Kanazawa M, Warita H, Aoki M, Fukudo S.

PLoS One. 2016 Jan 25;11(1):e0147817. doi: 10.1371/journal.pone.0147817. eCollection 2016.

20.

FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion.

Suzuki N, Aoki M, Warita H, Kato M, Mizuno H, Shimakura N, Akiyama T, Furuya H, Hokonohara T, Iwaki A, Togashi S, Konno H, Itoyama Y.

J Hum Genet. 2015 Oct;60(10):653-4. doi: 10.1038/jhg.2015.93. No abstract available.

PMID:
26500017
21.

[Recent progress in diagnosis and pathomechanism of inclusion body myositis].

Aoki M, Suzuki N, Kato M, Warita H.

Rinsho Shinkeigaku. 2014;54(12):1115-8. doi: 10.5692/clinicalneurol.54.1115. Japanese.

PMID:
25672724
22.

Proteasome dysfunction induces muscle growth defects and protein aggregation.

Kitajima Y, Tashiro Y, Suzuki N, Warita H, Kato M, Tateyama M, Ando R, Izumi R, Yamazaki M, Abe M, Sakimura K, Ito H, Urushitani M, Nagatomi R, Takahashi R, Aoki M.

J Cell Sci. 2014 Dec 15;127(Pt 24):5204-17. doi: 10.1242/jcs.150961. Epub 2014 Nov 6.

23.

GNE myopathy associated with congenital thrombocytopenia: a report of two siblings.

Izumi R, Niihori T, Suzuki N, Sasahara Y, Rikiishi T, Nishiyama A, Nishiyama S, Endo K, Kato M, Warita H, Konno H, Takahashi T, Tateyama M, Nagashima T, Funayama R, Nakayama K, Kure S, Matsubara Y, Aoki Y, Aoki M.

Neuromuscul Disord. 2014 Dec;24(12):1068-72. doi: 10.1016/j.nmd.2014.07.008. Epub 2014 Aug 8.

PMID:
25257349
24.

Immunolocalization of corticotropin-releasing hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial carcinoma: CRHR1 as a potent prognostic factor.

Sato N, Takagi K, Suzuki T, Miki Y, Tanaka S, Nagase S, Warita H, Fukudo S, Sato F, Sasano H, Ito K.

Int J Gynecol Cancer. 2014 Nov;24(9):1549-57. doi: 10.1097/IGC.0000000000000269.

25.

Exome sequencing identifies a novel TTN mutation in a family with hereditary myopathy with early respiratory failure.

Izumi R, Niihori T, Aoki Y, Suzuki N, Kato M, Warita H, Takahashi T, Tateyama M, Nagashima T, Funayama R, Abe K, Nakayama K, Aoki M, Matsubara Y.

J Hum Genet. 2013 May;58(5):259-66. doi: 10.1038/jhg.2013.9. Epub 2013 Feb 28.

PMID:
23446887
26.

ITIH4 and Gpx3 are potential biomarkers for amyotrophic lateral sclerosis.

Tanaka H, Shimazawa M, Takata M, Kaneko H, Tsuruma K, Ikeda T, Warita H, Aoki M, Yamada M, Takahashi H, Hozumi I, Minatsu H, Inuzuka T, Hara H.

J Neurol. 2013 Jul;260(7):1782-97. doi: 10.1007/s00415-013-6877-3. Epub 2013 Feb 23.

PMID:
23436019
27.

[Clinical translation of hepatocyte growth factor for amyotrophic lateral sclerosis].

Warita H, Kato M, Suzuki N, Itoyama Y, Aoki M.

Rinsho Shinkeigaku. 2012;52(11):1214-7. Japanese.

PMID:
23196568
28.

[Clinical genetics of amyotrophic lateral sclerosis in Japan: an update].

Aoki M, Warita H, Suzuki N, Kato M.

Rinsho Shinkeigaku. 2012;52(11):844-7. Japanese.

PMID:
23196439
29.

FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation.

Suzuki N, Kato S, Kato M, Warita H, Mizuno H, Kato M, Shimakura N, Akiyama H, Kobayashi Z, Konno H, Aoki M.

J Neuropathol Exp Neurol. 2012 Sep;71(9):779-88. doi: 10.1097/NEN.0b013e318264f164. Erratum in: J Neuropathol Exp Neurol. 2015 Sep;74(9):945.

PMID:
22878663
30.

Involvement of activated microglia in increased vulnerability of motoneurons after facial nerve avulsion in presymptomatic amyotrophic lateral sclerosis model rats.

Sanagi T, Nakamura Y, Suzuki E, Uchino S, Aoki M, Warita H, Itoyama Y, Kohsaka S, Ohsawa K.

Glia. 2012 May;60(5):782-93. doi: 10.1002/glia.22308. Epub 2012 Feb 16.

PMID:
22344792
31.

[Regenerative therapies for amyotrophic lateral sclerosis using hepatocyte growth factor].

Aoki M, Warita H, Suzuki N, Kato M, Itoyama Y.

Rinsho Shinkeigaku. 2011 Nov;51(11):1195-8. Japanese.

PMID:
22277532
32.

[Pathomechanism and prevalence of sporadic inclusion body myositis (sIBM)].

Suzuki N, Tateyama M, Warita H, Izumi R, Nishino I, Aoki M.

Rinsho Shinkeigaku. 2011 Nov;51(11):964-6. Japanese.

PMID:
22277440
33.

Continuous administration of poloxamer 188 reduces overload-induced muscular atrophy in dysferlin-deficient SJL mice.

Suzuki N, Akiyama T, Takahashi T, Komuro H, Warita H, Tateyama M, Itoyama Y, Aoki M.

Neurosci Res. 2012 Feb;72(2):181-6. doi: 10.1016/j.neures.2011.10.005. Epub 2011 Oct 21.

PMID:
22044584
34.

Feasibility study for functional test battery of SOD transgenic rat (H46R) and evaluation of edaravone, a free radical scavenger.

Aoki M, Warita H, Mizuno H, Suzuki N, Yuki S, Itoyama Y.

Brain Res. 2011 Mar 25;1382:321-5. doi: 10.1016/j.brainres.2011.01.058. Epub 2011 Jan 26.

PMID:
21276427
35.

An inducer of VGF protects cells against ER stress-induced cell death and prolongs survival in the mutant SOD1 animal models of familial ALS.

Shimazawa M, Tanaka H, Ito Y, Morimoto N, Tsuruma K, Kadokura M, Tamura S, Inoue T, Yamada M, Takahashi H, Warita H, Aoki M, Hara H.

PLoS One. 2010 Dec 9;5(12):e15307. doi: 10.1371/journal.pone.0015307.

36.

A case of McArdle disease: efficacy of vitamin B6 on fatigability and impaired glycogenolysis.

Izumi R, Suzuki N, Kato K, Warita H, Tateyama M, Nakashima I, Itoyama Y.

Intern Med. 2010;49(15):1623-5. Epub 2010 Aug 2. Review.

37.

Appearance of phagocytic microglia adjacent to motoneurons in spinal cord tissue from a presymptomatic transgenic rat model of amyotrophic lateral sclerosis.

Sanagi T, Yuasa S, Nakamura Y, Suzuki E, Aoki M, Warita H, Itoyama Y, Uchino S, Kohsaka S, Ohsawa K.

J Neurosci Res. 2010 Sep;88(12):2736-46. doi: 10.1002/jnr.22424.

PMID:
20648658
38.

Neuronal NOS is dislocated during muscle atrophy in amyotrophic lateral sclerosis.

Suzuki N, Mizuno H, Warita H, Takeda S, Itoyama Y, Aoki M.

J Neurol Sci. 2010 Jul 15;294(1-2):95-101. doi: 10.1016/j.jns.2010.03.022.

PMID:
20435320
39.

FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion.

Suzuki N, Aoki M, Warita H, Kato M, Mizuno H, Shimakura N, Akiyama T, Furuya H, Hokonohara T, Iwaki A, Togashi S, Konno H, Itoyama Y.

J Hum Genet. 2010 Apr;55(4):252-4. doi: 10.1038/jhg.2010.16. Epub 2010 Mar 12. Erratum in: J Hum Genet. 2015 Oct;60(10):653-4.

PMID:
20224596
40.

[Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor].

Aoki M, Warita H, Suzuki N, Itoyama Y.

Rinsho Shinkeigaku. 2009 Nov;49(11):814-7. Review. Japanese.

PMID:
20030218
41.

[Amyotrophic lateral sclerosis with the SOD1 mutations].

Aoki M, Warita H, Itoyama Y.

Rinsho Shinkeigaku. 2008 Nov;48(11):966-9. Review. Japanese.

PMID:
19198133
42.
43.

Accumulation of chondroitin sulfate proteoglycans in the microenvironment of spinal motor neurons in amyotrophic lateral sclerosis transgenic rats.

Mizuno H, Warita H, Aoki M, Itoyama Y.

J Neurosci Res. 2008 Aug 15;86(11):2512-23. doi: 10.1002/jnr.21702.

PMID:
18438943
44.

[Massive bleeding from tracheoarterial fistula in an amyotrophic lateral sclerosis patient treated with long-term invasive ventilation: an autopsy case report].

Kato K, Suzuki N, Aoki M, Warita H, Jin K, Itoyama Y.

Rinsho Shinkeigaku. 2008 Jan;48(1):60-2. Japanese.

PMID:
18386635
45.

Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model.

Ishigaki A, Aoki M, Nagai M, Warita H, Kato S, Kato M, Nakamura T, Funakoshi H, Itoyama Y.

J Neuropathol Exp Neurol. 2007 Nov;66(11):1037-44.

PMID:
17984685
46.

Clinical features of chromosome 16q22.1 linked autosomal dominant cerebellar ataxia in Japanese.

Onodera Y, Aoki M, Mizuno H, Warita H, Shiga Y, Itoyama Y.

Neurology. 2006 Oct 10;67(7):1300-2.

PMID:
17030774
47.

Parvalbumin and calbindin D-28k immunoreactivity in transgenic mice with a G93A mutant SOD1 gene.

Sasaki S, Warita H, Komori T, Murakami T, Abe K, Iwata M.

Brain Res. 2006 Apr 14;1083(1):196-203. Epub 2006 Mar 20.

PMID:
16546142
48.
49.

Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL).

Suzuki N, Aoki M, Hinuma Y, Takahashi T, Onodera Y, Ishigaki A, Kato M, Warita H, Tateyama M, Itoyama Y.

Neurosci Res. 2005 May;52(1):47-60.

PMID:
15811552
50.

Ultrastructural study of aggregates in the spinal cord of transgenic mice with a G93A mutant SOD1 gene.

Sasaki S, Warita H, Murakami T, Shibata N, Komori T, Abe K, Kobayashi M, Iwata M.

Acta Neuropathol. 2005 Mar;109(3):247-55. Epub 2004 Dec 22.

PMID:
15614580

Supplemental Content

Loading ...
Support Center